The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice-Reference-Cited by-同舟云学术

The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice

Published:2019-07-12 Issue:7 Volume:45 Page:188-199
ISSN:0190-2148
Container-title:Experimental Lung Research
language:en
Short-container-title:Experimental Lung Research

Author:

Okazaki Hiroyasu¹,Sato Seidai¹,Koyama Kazuya¹,Morizumi Shun¹,Abe Shuichi¹,Azuma Momoyo¹,Chen Yajuan¹,Goto Hisatsugu¹,Aono Yoshinori¹²,Ogawa Hirohisa³,Kagawa Kozo¹,Nishimura Haruka¹,Kawano Hiroshi¹,Toyoda Yuko¹,Uehara Hisanori³,Kouji Hiroyuki⁴⁵,Nishioka Yasuhiko¹

Affiliation:

1. Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan;

2. National Hospital Organization Higashi Tokushima Medical Center, Tokushima, Japan;

3. Department of Pathology and Laboratory Medicine, Tokushima University Graduate School, Tokushima, Japan;

4. PRISM BioLab Co., Ltd., Midori-ku, Yokohama, Japan;

5. Faculty of Medicine, Oita University, Yufu-city, Oita, Japan

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/01902148.2019.1638466

Reference31 articles.

1. Idiopathic pulmonary fibrosis

2. Pathogenesis of IPF

3. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline

4. Idiopathic Pulmonary Fibrosis: Aberrant Recapitulation of Developmental Programs?

5. WNT Signaling in Lung Disease

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why Is Wnt/β-Catenin Not Yet Targeted in Routine Cancer Care?;Pharmaceuticals;2024-07-16

2. Signaling pathways in liver cancer: pathogenesis and targeted therapy;Molecular Biomedicine;2024-05-31

3. Recent Advances in Signaling Pathways and Kinase Inhibitors for Leukemia Chemotherapy;Current Medicinal Chemistry;2024-02-16

4. Progress in the treatment of malignant ascites;Critical Reviews in Oncology/Hematology;2024-02

5. Protein lysine acetyltransferase CBP/p300: A promising target for small molecules in cancer treatment;Biomedicine & Pharmacotherapy;2024-02